Regional mutagenicity of heterocyclic amines in the intestine: Mutation analysis of the cII gene in lambda/lacZ transgenic mice

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 539, Issue 1-2, 2003, Pages 99-108

  Itoh, Toshiaki ^a,b   Kuwahara, Tomomi ^a   Suzuki, Takayoshi ^c   Hayashi, Makoto ^c   Ohnishi, Yoshinari ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Heterocyclic amine; Intestine; lacZ; Lambda cII; Mutant frequency

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 AMINO 3,4 DIMETHYLIMIDAZO[4,5 F]QUINOLINE; 3 AMINO 1 METHYL 5H PYRIDO[4,3 B]INDOLE; CARCINOGEN; HETEROCYCLIC AMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CELL ISOLATION; CII GENE; COLON; CONTROLLED STUDY; EPITHELIUM; GENE; GENE MUTATION; INTESTINE; LACZ GENE; MALE; MOUSE; MUTAGENICITY; MUTANT; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SAMPLE; SMALL INTESTINE; TRANSGENE; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0042388513     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(03)00134-7     Document Type: Article

References (33)

1. Gold L.S., Slone T.H., Stern B.R., Bernstein L. Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals. Mutat. Res. 286:1993;75-100.
2. Nagao M., Sugimura T. Carcinogenic factors in food with relevance to colon cancer development. Mutat. Res. 290:1993;43-51.
3. Gold L.S., Slone T.H., Manley N.B., Ames B.N. Heterocyclic amines formed by cooking food: comparison of bioassay results with other chemicals in the carcinogenic potency database. Cancer Lett. 83:1994;21-29.
4. Brooks R.A., Gooderham N.J., Zhao K., Edwards R.J., Howard L.A., Boobis A.R., Winton D.J. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent mutagen in the mouse small intestine. Cancer Res. 54:1994;1665-1671.
5. Zhang X.B., Felton J.S., Tucker J.D., Urlando C., Heddle J.A. Intestinal mutagenicity of two carcinogenic food mutagens in transgenic mice: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and amino(α)carboline. Carcinogenesis. 17:1996;2259-2265.
6. Lynch A.M., Gooderham N.J., Boobis A.R. Organ distinctive mutagenicity in Muta™Mouse after short-term exposure to PhIP. Mutagenesis. 11:1996;505-509.
7. Masumura K., Matsui K., Yamada M., Horiguchi M., Ishida K., Watanabe M., Ueda O., Suzuki H., Kanke Y., Tindall K.R., Wakabayashi K., Sofuni T., Nohmi T. Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the new gptΔ transgenic mouse. Cancer Lett. 143:1999;241-244.
8. ® lacI transgenic mice. Mutat. Res. 369:1996;45-49.
9. ®) mice. Mutat. Res. 468:2000;19-25.
10. Gossen J.A., De Leeuw W.J.F., Tan C.H.T., Zwarthoff E.C., Berends F., Lohman P.H.M., Knook D.L., Vijg J. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7971-7975.
11. Gold L.S., Sawyer C.B., Magaw R., Backman G.M., de Veciana M., Levinson R., Hooper N.K., Havender W.R., Bernstein L., Peto R., Pike M.C., Ames B.N. A carcinogenic potency database of the standardized results of animal bioassays. Environ. Health Perspect. 58:1984;9-319.
12. ® mice. Environ. Mol. Mutagen. 28:1996;348-353.
13. The Collaborative Study Group for the Transgenic Mouse Mutation Assay, Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan, Organ variation in the mutagenicity of ethylnitrosourea in Muta™Mouse: results of the collaborative study on the transgenic mutation assay by JEMS/MMS. Environ. Mol. Mutagen. 28 (1996) 363-375.
14. Jakubczak J.L., Merlino G., French J.E., Muller W.J., Paul B., Adhya S., Garges S. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage λ transgene target. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9073-9078.
15. Suzuki T., Wang X., Miyata Y., Saeki K., Kohara A., Kawazoe Y., Hayashi M., Sofuni T. Hepatocarcinogen quinoline induces G:C to C:G transversions in the cII gene in the liver of lambda/lacZ transgenic mice (Muta™Mouse). Mutat. Res. 456:2000;73-81.
16. Bielas J.H., Heddle J.A. Proliferation is necessary for both repair and mutation in transgenic mouse cells. Proc. Natl. Acad. Sci. U.S.A. 97:2000;11391-11396.
17. Kato R. Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates. CRC Crit. Rev. Toxicol. 16:1986;307-348.
18. Josyula S., Schut H.A. Dietary omega-3 fatty acids as potential inhibitors of carcinogenesis: effect on DNA adduct formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice and rats. Food Chem. Toxicol. 37:1999;287-296.
19. Schut H.A., Wang C.L., Twining L.M., Earle K.M. Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in CDF1 mice fed a high ω-3 fatty acid diet. Mutat. Res. 378:1997;23-30.
20. Ito N., Hasegawa R., Sano M., Tamano S., Esumi H., Takayama S., Sugimura T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 12:1991;1503-1506.
21. Esumi H., Ohgaki H., Kohzen E., Takayama S., Sugimura T. Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res. 80:1989;1176-1178.
22. Kristiansen E., Mortensen A., Sørensen I.K. Effects of long-term feeding with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in C57BL/ ByA and Eμ-pim-1 mice. Cancer Lett. 122:1998;215-220.
23. Okonogi H., Stuart G.R., Okochi E., Ushijima T., Sugimura T., Glickman B.W., Nagao M. Effects of gender and species on spectra of mutation induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the lacI transgene. Mutat. Res. 395:1997;93-99.
24. ® rats. Mutat. Res. 452:2000;101-121.
25. Stuart G.R., de Boer J.G., Haesevoets R., Holcroft J., Kangas J., Sojonky K., Thorleifson E., Thornton A., Walsh D.F., Yang H., Glickman B.W. Mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in cecum and proximal and distal colon of lacI transgenic rats. Mutagenesis. 16:2001;431-437.
26. Fujita H., Nagano K., Ochiai M., Ushijima T., Sugimura T., Nagao M., Matsushima T. Difference in target organs in carcinogenesis with a heterocyclic amine, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, in different strains of mice. Jpn. J. Cancer Res. 90:1999;1203-1206.
27. Ohgaki H., Hasegawa H., Suenaga M., Kato T., Sato S., Takayama S., Sugimura T. Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethylimidazo[4,5-f]quinoline. Carcinogenesis. 7:1986;1889-1893.
28. Ohgaki H., Hasegawa H., Kato T., Suenaga M., Ubukata M., Sato S., Takayama S., Sugimura T. Carcinogenicity in mice and rats of heterocyclic amines in cooked foods. Environ. Health Perspect. 67:1986;129-134.
29. ® rats treated with 2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis. 21:2000;1-6.
30. Kohara A., Suzuki T., Honma M., Hirano N., Ohsawa K., Ohwada T., Hayashi M. Mutation spectrum of o-aminoazotoluene in the cII gene of lambda/lacZ transgenic mice (Muta™Mouse). Mutat. Res. 491:2001;211-220.
31. Kohara A., Suzuki T., Honma M., Oomori T., Ohwada T., Hayashi M. Dinitropyrenes induce gene mutations in multiple organs of the lambda/lacZ transgenic mouse (Muta™Mouse). Mutat. Res. 515:2002;73-83.
32. Kohara A., Suzuki T., Honma M., Ohwada T., Hayashi M. Mutagenicity of aristolochic acid in the lambda/lacZ transgenic mouse (Muta™Mouse). Mutat. Res. 515:2002;63-72.
33. Lynch A.M., Gooderham N.J., Davies D.S., Boobis A.R. Genetic analysis of PhIP intestinal mutations in Muta™Mouse. Mutagenesis. 13:1998;601-605.